Intech Biopharm Corporation (TPEX:6461)
22.00
+1.70 (8.37%)
Jun 16, 2025, 1:30 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 2.80 billion as of June 13, 2025. Its market cap has decreased by -25.08% in one year.
Market Cap
2.80B
Enterprise Value
4.11B
Revenue
32.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.00
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 2.80B, a decrease of -30.07%. That is a compound annual growth rate of -3.22%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
PharmaEssentia | 179.30B |
Caliway Biopharmaceuticals | 154.14B |
Bora Pharmaceuticals Co., LTD. | 83.48B |
Lotus Pharmaceutical | 57.19B |
Oneness Biotech | 36.59B |
Polaris Group | 30.70B |
Lumosa Therapeutics | 27.77B |
Center Laboratories | 27.39B |